SkinnyRx programs and current prices
0 comparison programs and 4 additional listings, checked 29 August 2026.
| Treatment | Current monthly price | Format | Visit |
|---|---|---|---|
| GLP-1 treatment | |||
 Compounded Injectable Semaglutide | From $199/mo • exact renewal price depends on the selected plan | Weekly subcutaneous injection | Visit |
 Compounded Semaglutide Tablets | From $249/mo • exact renewal price depends on the selected plan | Daily sublingual tablet | Visit |
 Compounded Injectable Tirzepatide | From $299/mo • exact renewal price depends on the selected plan | Weekly subcutaneous injection | Visit |
 Compounded Tirzepatide Tablets | From $299/mo • exact renewal price depends on the selected plan | Daily sublingual tablet | Visit |
Verdict: format choice is the strength, regulatory history is the drawback
SkinnyRx is most relevant to a cash-pay reader choosing among injectable and non-injectable compounded semaglutide or tirzepatide. Its site publishes product pages, clinician review, shipping, and support details. The catalog figures are starting prices, however, and Telehealth Ledger does not treat them as universal continuing rates.
The decisive drawback is an FDA warning letter issued to Lean Rx, Inc. doing business as SkinnyRx. FDA said reviewed website claims and imagery falsely or misleadingly represented compounded products, including implications about approval and who compounded them. That record does not prove every current prescription is unsafe, but it is material and should be weighed before enrollment.
Starting prices belong in listings, not a flat-rate ranking
SkinnyRx has canonical listings for four compounded GLP-1 formats. The checked pages use from or as-low-as language, so the amounts are displayed with their basis rather than converted into a continuing monthly offer.
Compare injectable semaglutide with injectable semaglutide and oral formats with other oral formats. Do not assume that an oral compounded product is clinically interchangeable with an FDA-approved tablet or an injection. Confirm the formulation, total plan charge, dose-dependent changes, and refill term at checkout.
Lean Rx operates the storefront while clinicians prescribe
The current terms identify Lean Rx, Inc. as the administrative operator and state that it is not itself a healthcare provider. Independent affiliated medical practices and U.S.-licensed clinicians review intake information and prescribe only when they judge treatment appropriate.
SkinnyRx describes fulfillment through a partner pharmacy, but the sources checked for the local dossier do not name one fixed pharmacy for every patient. Ask which pharmacy will fill the exact prescription and verify that entity on the medication label. The brand name on a website is not a substitute for the compounder's identity.
The refund boundary moves when prescription review finishes
The FAQ describes a full-refund boundary before prescription review is completed. The terms add limits for fulfillment, shipped products, bundles, partial periods, promotions, and guarantee language. They also advise cancelling before renewal processing rather than waiting until a new shipment is prepared.
A reader should save the selected plan length and renewal date, then request cancellation in writing early enough to receive confirmation. Financing can separate payment obligations from shipment timing, so a provider cancellation and a financing agreement may require different actions.
What the FDA warning letter actually says
FDA's February 2026 letter says the agency reviewed SkinnyRx website content from December 2025. It objected to imagery suggesting SkinnyRx was the compounder and to claims that FDA said implied compounded semaglutide and tirzepatide products had FDA approval or evaluation they did not have.
The letter concerns marketing and misbranding. It is not a batch test, recall, or finding that every dispensing pharmacy failed quality standards. The correct takeaway is narrower and still important: compounded drugs are not FDA-approved products, and a storefront should not blur the roles of brand, prescriber, and compounder.
Trustpilot and BBB show a wide reputational split
SkinnyRx's claimed Trustpilot profile is strongly positive and says the company asks customers for reviews. BBB's profile is not accredited and cites a substantial complaint record, with recent reports focused on cancellation, charges, and fulfillment. Neither source should be read alone.
Consumer reviews are most useful for spotting operational questions. They cannot prove medication contents, clinical appropriateness, or representative weight loss. The FDA letter carries more authority for the specific marketing violations it describes, while the terms control the customer's current cancellation and refund position.
Alternatives for readers who want firmer boundaries
Choose a provider with a disclosed flat continuing price if price predictability is the priority. Compare FDA-approved branded pathways when product approval status matters more than cash-pay convenience. A provider that names the dispensing pharmacy before purchase may better fit someone focused on pharmacy verification.
SkinnyRx offers unusual format breadth, but that choice does not erase the starting-price limitation or the FDA record. The best candidate is prepared to verify formulation, pharmacy, full plan cost, and renewal terms before authorizing payment.
Oral and injectable products require separate evidence
SkinnyRx's four-format catalog creates genuine choice, but a tablet, injection, and branded oral drug cannot be grouped simply because they share part of a medication name. Route and formulation affect absorption, evidence, handling, and the product a clinician is actually prescribing. The oral compounded listings should therefore be compared only with records that disclose a sufficiently similar formulation. Telehealth Ledger does not borrow efficacy findings from an FDA-approved injection or tablet and apply them to a different compounded oral product.
Before accepting an oral option, ask for the complete active-ingredient description, dosage form, dispensing pharmacy, directions on the patient-specific label, and the evidence the clinician uses for that formulation. Before accepting an injection, confirm the concentration, supplies, storage, and what to do if a shipment arrives outside the pharmacy's stated conditions. These are verification questions, not individualized dosing instructions. A patient should follow the prescriber and pharmacy label, and contact the responsible clinician when the delivered product does not match the prescription or expected format.
How this review was prepared
We checked SkinnyRx’s public pricing and programme pages on 29 August 2026. The review covers published pricing, plan terms, inclusions, and availability. It is not a rating, a clinical assessment, or a guarantee of eligibility or outcomes.
- SkinnyRx treatment catalog
- SkinnyRx injectable semaglutide product page
- SkinnyRx FAQ
- SkinnyRx terms
- FDA warning letter to Lean Rx, Inc. dba SkinnyRx
- BBB profile for SkinnyRx
- Trustpilot profile for skinnyrx.com
Evidence limits
- The current catalog records are starting-price listings and are intentionally excluded from flat continuing-price rankings.
- The FDA letter addresses reviewed marketing content and must not be expanded into an unsupported claim about every current prescription or pharmacy batch.
- Compounded offerings are excluded in Alabama, Louisiana, and Mississippi under the checked terms; eligibility can change.